Estrogen’s effects on immune cell function are an area that could be particularly important, as this could not only explain differences in cancer initiation and progression, but also immunotherapy response and potential combinations of immunotherapies with other therapies, potentially aromatase inhibitors that would prevent estrogen production. The gene discussed is CYP19A1; the disease is cancer.